...
首页> 外文期刊>Frontiers in Pediatrics >Early Urinary Biomarkers in Pediatric Autosomal Dominant Polycystic Kidney Disease (ADPKD): No Evidence in the Interest of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL)
【24h】

Early Urinary Biomarkers in Pediatric Autosomal Dominant Polycystic Kidney Disease (ADPKD): No Evidence in the Interest of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL)

机译:早期尿生物标志物在儿科常染色体显性多囊肾病(ADPKD):没有尿液中性粒细胞明胶酶相关脂素(UNGAL)的兴趣没有证据

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is increasingly diagnosed during childhood by the presence of renal cysts in patients with a positive familial history. No curative treatment is available and early detection and diagnosis confronts pediatricians with the lack of early markers to decide whether a nephroprotective treatment should be introduced and prevent the progression of renal failure. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is a tubular protein that has been recently proposed as an early biomarker of renal impairment in the ADPKD adult population. Methods: Urinary NGAL (uNGAL) levels were measured in 15 ADPKD children and compared with 15 age and gender matched controls using parametric, non-parametric and Bayesian statistics. We also tested the association of uNGAL levels with markers of disease progression, such as proteinuria, albuminuria, blood pressure and Total Kidney Volume (TKV) using correlation analysis. Results: No difference in mean uNGAL levels was observed between groups (ADPKD: 26.36 ng/ml; Controls: 27.24 ng/ml; P=.96). Moreover, no correlation was found between uNGAL and proteinuria (P=.51), albuminuria (P=.69), TKV (P=.68) or mean arterial pressure (P=.90). By contrast, TKV was positively correlated with proteinuria (P=.04), albuminuria (P=.001) and mean arterial pressure (P=.03). Conclusion: uNGAL did not confirm its superiority as a marker of disease progression in a pediatric ADPKD population. In the contrary, TKV appears to be an easy measurable variable and may be promising as a surrogate marker to follow ADPKD progression in children.
机译:背景:常染色体显性多囊肾疾病(ADPKD)在童年期间越来越诊断为患者患有阳性家族史的肾囊肿。没有治疗治疗,早期检测和诊断面对儿科医生,缺乏早期标记,以决定是否应介绍肾脏反应治疗并防止肾功能衰竭的进展。中性粒细胞明胶酶相关的脂素(NGAL)是一种管状蛋白,最近被提出为ADPKD成年人群的肾损伤的早期生物标志物。方法:在15种ADPKD儿童中测量尿NGAL(UNGAL)水平,并使用参数,非参数和贝叶斯统计数据与15岁和性别匹配对照进行比较。我们还测试了UNGAL水平与疾病进展标记的关联,例如蛋白尿,白蛋白尿,血压和使用相关性分析的总肾脏体积(TKV)。结果:在组之间观察到平均UNGAL水平的差异(ADPKD:26.36 ng / ml;对照:27.24 ng / ml; p = .96)。此外,UNGAL和蛋白尿(P = .51)之间没有发现相关性,白蛋白尿(P = .69),TKV(P = .68)或平均动脉压(P = .90)。相比之下,TKV与蛋白尿(P = 0.04),白蛋白尿(P = .001)和平均动脉压(P = .03)呈正相关。结论:UNGAL并未证实其优越性作为儿科ADPKD人群中疾病进展的标志。相反,TKV似乎是一种易于可测量的变量,并且可能是遵循儿童ADPKD进展的替代标记。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号